NCT06493656

Brief Summary

This clinical trial investigates whether concomitant capsule-preserving hydrodilatation (CSHD) is more effective than isolated glenohumeral corticosteroid injection (CS) in treating shoulder adhesive capsulitis. The main questions it aims to answer are

  • Is CSHD inferior to CS in immediate pain relief as the solution is diluted?
  • Is CSHD superior to CS in improving the range of motion as the contracted capsule is dilated? Group CS will receive an ultrasound-guided glenohumeral corticosteroid injection only, with a solution of 5 mL. Group CSHD will receive an ultrasound-guided glenohumeral corticosteroid with hydrodilatation, with a solution of 20 mL. Clinical scores and range of motion will be compared between the groups up to six months post-injection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 17, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 17, 2015

Completed
8.6 years until next milestone

First Submitted

Initial submission to the registry

June 24, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 10, 2024

Completed
Last Updated

July 10, 2024

Status Verified

July 1, 2024

Enrollment Period

2 years

First QC Date

June 24, 2024

Last Update Submit

July 7, 2024

Conditions

Keywords

Glenohumeral injectionHydrodilatationCorticosteroid injection

Outcome Measures

Primary Outcomes (1)

  • Visual analog scale (VAS) for pain

    Patient-reported 0-10 scale of pain, 0: no pain, 10: very severe pain

    Change from the baseline to 6 months

Secondary Outcomes (3)

  • Range of motion (ROM)

    Change from the baseline to 6 months

  • American Shoulder and Elbow Surgeons (ASES) shoulder score

    Change from the baseline to 6 months

  • Constant-Murley score

    Change from the baseline to 6 months

Study Arms (2)

Isolated corticosteroid injection

EXPERIMENTAL

Ultrasound-guided posterior approach of glenohumeral space injection for adhesive capsulitis of the shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine.

Procedure: Ultrasound-guided glenohumeral space isolated corticosteroid injectionDrug: 1mL of Triamcinolone (40mg/1mL) Injectable SolutionDrug: 4mL of Lidocaine 1% Solution Injectable Solution

Concomitant hydrodilatation with corticosteroid injection

ACTIVE COMPARATOR

Ultrasound-guided posterior approach of glenohumeral space hydrodilatation for adhesive capsulitis of the shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, and 15 mL normal saline

Procedure: Ultrasound-guided glenohumeral space concomitant hydrodilatation with corticosteroid injectionDrug: 1mL of Triamcinolone (40mg/1mL) Injectable SolutionDrug: 4mL of Lidocaine 1% Solution Injectable SolutionDrug: 15mL of Normal Saline

Interventions

Using a 21-gauge spinal needle, the predefined steroid solution was injected under ultrasound guidance using 5- to 13-MHz linear probe into the glenohumeral space through the posterior approach.

Isolated corticosteroid injection

Using a 21-gauge spinal needle, the predefined steroid solution with additional 15 mL of normal saline was injected under ultrasound guidance using 5- to 13-MHz linear probe into the glenohumeral space through the posterior approach.

Concomitant hydrodilatation with corticosteroid injection

1mL of Triamcinolone 40mg/1mL solution was included in the injection/hydrodilatation regimen.

Concomitant hydrodilatation with corticosteroid injectionIsolated corticosteroid injection

4mL of 1% Lidocaine solution was included in the injection/hydrodilatation regimen.

Concomitant hydrodilatation with corticosteroid injectionIsolated corticosteroid injection

15mL of 1% Lidocaine solution was included in the hydrodilatation regimen.

Concomitant hydrodilatation with corticosteroid injection

Eligibility Criteria

Age35 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Two or more of the following criteria within the shoulder's range of motion:
  • Abduction and forward elevation below 100˚
  • External rotation at the side below 30˚
  • Internal rotation at 90˚ of abduction below 30˚

You may not qualify if:

  • History of shoulder surgery, trauma, nerve injury
  • Concomitant rotator cuff/biceps lesions in ultrasound or MRI
  • Glenohumeral arthritis in simple X-ray
  • Calcific tendinosis in simple X-ray
  • Underlying conditions: cancer, mental illness, hormonal imbalance
  • Diabetes with HbA1c levels exceeding 7.0%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chuncheon Sacred Heart Hospital

Chuncheon, Gangwondo, 700-204, South Korea

Location

Related Publications (6)

  • Neviaser AS, Hannafin JA. Adhesive capsulitis: a review of current treatment. Am J Sports Med. 2010 Nov;38(11):2346-56. doi: 10.1177/0363546509348048. Epub 2010 Jan 28.

  • Cho CH, Lee YH, Kim DH, Lim YJ, Baek CS, Kim DH. Definition, Diagnosis, Treatment, and Prognosis of Frozen Shoulder: A Consensus Survey of Shoulder Specialists. Clin Orthop Surg. 2020 Mar;12(1):60-67. doi: 10.4055/cios.2020.12.1.60. Epub 2020 Feb 13.

  • Redler LH, Dennis ER. Treatment of Adhesive Capsulitis of the Shoulder. J Am Acad Orthop Surg. 2019 Jun 15;27(12):e544-e554. doi: 10.5435/JAAOS-D-17-00606.

  • Catapano M, Mittal N, Adamich J, Kumbhare D, Sangha H. Hydrodilatation With Corticosteroid for the Treatment of Adhesive Capsulitis: A Systematic Review. PM R. 2018 Jun;10(6):623-635. doi: 10.1016/j.pmrj.2017.10.013. Epub 2017 Nov 10.

  • Oh JH, Oh CH, Choi JA, Kim SH, Kim JH, Yoon JP. Comparison of glenohumeral and subacromial steroid injection in primary frozen shoulder: a prospective, randomized short-term comparison study. J Shoulder Elbow Surg. 2011 Oct;20(7):1034-40. doi: 10.1016/j.jse.2011.04.029. Epub 2011 Aug 4.

  • Kim DY, Lee SS, Nomkhondorj O, Cho MG, Lee JJ, Hwang JT, Hong MS. Comparison Between Anterior and Posterior Approaches for Ultrasound-Guided Glenohumeral Steroid Injection in Primary Adhesive Capsulitis: A Randomized Controlled Trial. J Clin Rheumatol. 2017 Jan;23(1):51-57. doi: 10.1097/RHU.0000000000000475. No abstract available.

MeSH Terms

Conditions

Bursitis

Interventions

Adrenal Cortex HormonesTriamcinoloneLidocaineSaline Solution

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

HormonesHormones, Hormone Substitutes, and Hormone AntagonistsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Jung Taek Hwang, MD, PhD

    Chuncheon Sacred Heart Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
A final number of 50 patients were enrolled in the trial and randomly assigned to either the isolated corticosteroid injection group (Group CS) or the concomitant hydrodilatation group (Group CSHD). Double-blinded randomization was performed by an independent nurse using a computer-generated random sequence. A musculoskeletal radiologist, blinded to group allocation, performed the diagnostic ultrasound and MRI interpretations. A blinded orthopaedic nurse carried out the physical examination and clinical scoring.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Study group underwent ultrasound-guided posterior approach of glenohumeral space injection for adhesive capsulitis of the shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 7 mL normal saline. Control group underwent ultrasound-guided posterior approach of glenohumeral space HYDRODILATATION for adhesive capsulitis of the shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 15 mL normal saline.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 24, 2024

First Posted

July 10, 2024

Study Start

December 5, 2013

Primary Completion

November 17, 2015

Study Completion

November 17, 2015

Last Updated

July 10, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations